UK Statutory Scheme Rebate Rise Could Cause Product Shortages & Launch Delays

 
• By Leela Barham

The pharmaceutical industry is calling on the government to take steps to restore the UK as a location for life sciences investment and recognize the role of competition in the branded generics market, but it will need strong evidence to make the most convincing case.

Close-up shot of pills with stamped pound sterling GBP symbol on them.
The statutory scheme is one way to govern drug prices in the UK • Source: Shutterstock

More from Europe

More from Geography